Most recent news

19 January

2017

Firm news

Boult Wade Tennant ranked top tier by The World Trademark Review 1000 2017

Excellent news for Bout Wade Tennant’s Trade Mark Group, as the release of the annual World Trademark Review (WTR 1000) results saw the award-winning group honoured with another top tier ranking within the UK Trade Mark Agency category. Each year WTR 1000 celebrates the incredible achievements of the world’s leading trade mark professionals, highlighting quality... right arrow

3 January

2017

Firm news

Voluntary vacation scheme 2017

We are pleased to announce the application process for the voluntary vacation scheme is now open. Please click here for more information and to apply. The closing date for applications is 28 April 2017. right arrow

28 November

2016

Firm news

Resounding success at the EPO for Biotech team

Matthew Spencer and James Legg, representing Adaptive Biotechnologies Corporation, successfully defended European Patent No. 2 364 368 at the European opposition hearing on 16 November 2016. The Patent, which had been opposed by three opponents, provides broad protection for immune profiling using next-generation sequencing (NGS). Adaptive Biotechnologies Corporation is the pioneer and leader in combining... right arrow

24 November

2016

Firm news

Felicity Hide and Luke Portnow feature in ECTA magazine

Boult Wade Tennant Partner, Felicity Hide and Attorney, Luke Portnow feature in the latest edition of the European Communities Trade Mark Association (ECTA) magazine. Exploring the difficulty with colour combination Trade Marks in the UK, the article focuses on Glaxo v Sandoz [2016] EWHC 1537 and the recent UK decision by the High Court to... right arrow

8 November

2016

Firm news

Boult Wade Tennant ranked top tier in Chambers and Partners 2017

We are thrilled to announce that Boult Wade Tennant has maintained tier one status in the Intellectual Property: Patent & Trade Mark Attorneys – UK-wide category by prestigious legal directory Chambers and Partners. Senior Partner and Head of Biotechnology and Life Sciences Group, Claire Baldock comments: “To once again be recognised by Chambers and Partners... right arrow

1 20 21 22 23 24 40